Answers are grounded in this paper and cite their sources.
Antineutrophil cytoplasmic autoantibody (ANCA)–associated glomerulonephritis after vaccination with the Pfizer-BioNTech COVID-19 vaccine has been recently reported.1 We describe 2 patients who developed double-positive ANCA and antiglomerular basement membrane (GBM) disease within 2 weeks of receiving BBV152/Covaxin (Bharat Biotech, India) vaccination (Table 1).
No takes yet. Share an insight, caveat, or question.
Prema et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: